Chemicals and intermediates used in pharmaceutical manufacturing and drug development.
chemXplore tracks 177 projects in pharma, of which 68 are active.
Of the active ones, 37 expansion, 28 new construction and 3 revamp / retrofit.
24 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
The accelerated approval covers adults with advanced disease after alectinib alone, or after at least two ALK inhibitors and platinum chemotherapy.
AI and automated equipment design, run and evaluate API process experiments, with reported throughput of up to 100 experiments a day.
The deal would add OLN324, a Phase 3 bispecific antibody candidate for retinal diseases, to its ophthalmology pipeline.
In the phase 3 STEP Young trial, BMI fell over 68 weeks with semaglutide alongside diet and activity changes; the treatment remains investigational for children under 12 in the US.
Findings span an ovariectomized-rat model, small human biomarker studies and exploratory analyses from the 68-week REDEFINE 1 trial.
The oral giredestrant–everolimus regimen cut the risk of progression or death by 62% versus endocrine therapy plus everolimus in phase III testing.
A post hoc analysis of REDEFINE 1 found 67.8% reached at least 5% weight loss by week 8; separate analyses reported improved physical and psychosocial function.
The approval covers adults at risk of disease progression and follows Phase III results showing higher remission rates than tacrolimus.
The 68-week REDEFINE 9 study compared two dose levels with placebo in 309 adults with overweight or obesity without diabetes.
The subcutaneous treatment offers monthly, every-two-weeks or weekly prophylaxis via a single-use pre-filled pen.
active all projects
The 8 with the most active projects, of 27 countries.